Literature DB >> 12374847

Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease.

B Urbanc1, L Cruz, R Le, J Sanders, K Hsiao Ashe, K Duff, H E Stanley, M C Irizarry, B T Hyman.   

Abstract

Despite extensive deposition of putatively neurotoxic amyloid-beta (Abeta) protein in the brain, it has not been possible to demonstrate an association of Abeta deposits with neuronal loss in Alzheimer's disease (AD), and neuronal loss is minimal in transgenic mouse models of AD. Using triple immunostaining confocal microscopy and analyzing the images with the cross-correlation density map method from statistical physics, we directly compared Abeta deposition, Abeta morphology, and neuronal architecture. We found dramatic, focal neuronal toxicity associated primarily with thioflavin S-positive fibrillar Abeta deposits in both AD and PSAPP mice. These results, along with computer simulations, suggest that Abeta develops neurotoxic properties in vivo when it adopts a fibrillar beta-pleated sheet conformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374847      PMCID: PMC137824          DOI: 10.1073/pnas.222433299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease.

Authors:  R B Knowles; C Wyart; S V Buldyrev; L Cruz; B Urbanc; M E Hasselmo; H E Stanley; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

3.  Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.

Authors:  Y Matsuoka; M Picciano; J La Francois; K Duff
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.

Authors:  S Jaffar; S E Counts; S Y Ma; E Dadko; M N Gordon; D Morgan; E J Mufson
Journal:  Exp Neurol       Date:  2001-08       Impact factor: 5.330

5.  Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.

Authors:  J Götz; F Chen; J van Dorpe; R M Nitsch
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

6.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

7.  Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.

Authors:  A Takeuchi; M C Irizarry; K Duff; T C Saido; K Hsiao Ashe; M Hasegawa; D M Mann; B T Hyman; T Iwatsubo
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

Authors:  Sonia Boncristiano; Michael E Calhoun; Peter H Kelly; Michelle Pfeifer; Luca Bondolfi; Martina Stalder; Amie L Phinney; Dorothee Abramowski; Christine Sturchler-Pierrat; Albert Enz; Bernd Sommer; Matthias Staufenbiel; Mathias Jucker
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

9.  The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.

Authors:  T Gómez-Isla; W B Growdon; M J McNamara; D Nochlin; T D Bird; J C Arango; F Lopera; K S Kosik; P L Lantos; N J Cairns; B T Hyman
Journal:  Brain       Date:  1999-09       Impact factor: 13.501

10.  Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.

Authors:  A Lorenzo; M Yuan; Z Zhang; P A Paganetti; C Sturchler-Pierrat; M Staufenbiel; J Mautino; F S Vigo; B Sommer; B A Yankner
Journal:  Nat Neurosci       Date:  2000-05       Impact factor: 24.884

View more
  92 in total

1.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.

Authors:  Caty Casas; Nicolas Sergeant; Jean-Michel Itier; Véronique Blanchard; Oliver Wirths; Nicolien van der Kolk; Valérie Vingtdeux; Evita van de Steeg; Gwenaëlle Ret; Thierry Canton; Hervé Drobecq; Allan Clark; Bruno Bonici; André Delacourte; Jesús Benavides; Christoph Schmitz; Günter Tremp; Thomas A Bayer; Patrick Benoit; Laurent Pradier
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

2.  Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology.

Authors:  Markus Morawski; Gert Brückner; Carsten Jäger; Gudrun Seeger; Russel T Matthews; Thomas Arendt
Journal:  Brain Pathol       Date:  2012-01-13       Impact factor: 6.508

3.  Binding modes of thioflavin T molecules to prion peptide assemblies identified by using scanning tunneling microscopy.

Authors:  Xiaobo Mao; Yuanyuan Guo; Chenxuan Wang; Min Zhang; Xiaojing Ma; Lei Liu; Lin Niu; Qingdao Zeng; Yanlian Yang; Chen Wang
Journal:  ACS Chem Neurosci       Date:  2011-03-30       Impact factor: 4.418

4.  Topological analyses in APP/PS1 mice reveal that astrocytes do not migrate to amyloid-β plaques.

Authors:  Elena Galea; Will Morrison; Eloise Hudry; Michal Arbel-Ornath; Brian J Bacskai; Teresa Gómez-Isla; H Eugene Stanley; Bradley T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

Review 5.  Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models.

Authors:  Jennifer I Luebke; Christina M Weaver; Anne B Rocher; Alfredo Rodriguez; Johanna L Crimins; Dara L Dickstein; Susan L Wearne; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-02-24       Impact factor: 3.270

Review 6.  Nanoimaging for protein misfolding and related diseases.

Authors:  Yuri L Lyubchenko; Simon Sherman; Luda S Shlyakhtenko; Vladimir N Uversky
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

7.  Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.

Authors:  Neha Kohli; Donevan R Westerveld; Alexandra C Ayache; Amrisha Verma; Pollob Shil; Tuhina Prasad; Ping Zhu; Sic L Chan; Qiuhong Li; Henry Daniell
Journal:  Mol Ther       Date:  2013-12-06       Impact factor: 11.454

8.  Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy.

Authors:  Tara L Spires; Melanie Meyer-Luehmann; Edward A Stern; Pamela J McLean; Jesse Skoch; Paul T Nguyen; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

9.  Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.

Authors:  Jennifer B Paulson; Martin Ramsden; Colleen Forster; Mathew A Sherman; Eileen McGowan; Karen H Ashe
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

10.  Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.

Authors:  Thierry Bussière; Frédérique Bard; Robin Barbour; Henry Grajeda; Terry Guido; Karen Khan; Dale Schenk; Dora Games; Peter Seubert; Manuel Buttini
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.